Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Completed × Chalazion × Clear all

Phase

Phase NA 3 Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 590 Neoplasms 295 Carcinoma, Non-Small-Cell Lung 280 Prostatic Neoplasms 266 Colorectal Neoplasms 211 Multiple Myeloma 181 Lung Neoplasms 149 Neoplasm Metastasis 138 Leukemia, Myeloid, Acute 124 Leukemia 120 Lymphoma 114 Lymphoma, Follicular 113 Stomach Neoplasms 104 Lymphoma, Non-Hodgkin 102 Colonic Neoplasms 97 Ovarian Neoplasms 95 Rectal Neoplasms 94 Precursor Cell Lymphoblastic Leukemia-Lymphoma 93 Uterine Cervical Neoplasms 92 Head and Neck Neoplasms 92 Leukemia, Lymphocytic, Chronic, B-Cell 91 Pain 90 Carcinoma, Hepatocellular 85 Pancreatic Neoplasms 80 Melanoma 78 Lymphoma, Large B-Cell, Diffuse 76 Papillomavirus Infections 68 Recurrence 66 Squamous Cell Carcinoma of Head and Neck 64 Keratosis, Actinic 61

Interventions

tyramine-deoxysorbitol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03248440 2021-08-05

SUNRISE

Senju USA, Inc.

Phase 3 Completed

263 enrolled 7 charts

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡